| ALK | Anaplastic Lymphoma Kinase |
| AUC | Area Under the Curve |
| bFGF | Basic Fibroblast Growth Factor |
| CD40L | CD40 Ligand |
| CTCs | Circulating Tumor Cells |
| ctDNA | Circulating Tumor DNA |
| EGF | Epidermal Growth Factor |
| EGFR | Epidermal Growth Factor Receptor |
| EGFRvIII | Epidermal Growth Factor Receptor Variant III |
| EML4 | Echinoderm Microtubule Associated Protein-Like 4 |
| EMT | Epithelial–Mesenchymal Transition |
| EVs | Extracellular Vesicles |
| EZH2 | Enhancer of Zeste Homolog 2 |
| GARP | TGFβ Docking Receptor Glycoprotein A Repetitions Predominant |
| G-CSF | Granulocyte Colony Stimulating Factor |
| GM-CSF | Granulocyte Macrophage-Colony Stimulating Factor |
| GPIIb/IIIa | Glycoprotein IIb/IIIa |
| IL-6 | Interleukin-6 |
| KRAS | Kirsten Rat Sarcoma Virus |
| MALAT1 | Metastasis Associated Lung Adenocarcinoma Transcript 1 |
| MDSCs | Myeloid-Derived Suppressor Cells |
| MHC | Major Histocompatibility Complex |
| MIBC | Muscle-Invasive Bladder Cancer |
| mCRPC | Metastatic Castration-Resistant Prostate Cancer |
| MMPs | Metalloproteinases |
| NK Cells | Natural Killer Cells |
| NSCLC | Non-Small Cell Lung Cancer |
| OS | Overall Survival |
| PCA3 | Prostate Cancer Antigen 3 |
| PDGF | Platelet-Derived Growth Factor |
| PD-L1 | Programmed Death Ligand 1 |
| PIK3CA | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Alpha |
| PFS | Progression-Free Survival |
| PSA | Prostate-Specific Antigen |
| PSMA | Prostate-Specific Membrane Antigen |
| RCC | Renal Cell Carcinoma |
| TAMs | Tumor-Associated Macrophages |
| TEPs | Tumor-Educated Platelets |
| TGF-β | Transforming Growth Factor-Beta |
| TIMP1 | TIMP Metallopeptidase Inhibitor 1 |
| TME | Tumor Microenvironment |
| Tregs | Regulatory T Cells |
| TSP-1 | Thrombospondin-1 |
| VEGF | Vascular Endothelial Growth Factor |